Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers' Menstrual Patterns
NCT04854408 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2021-05-11
Summary
Coronavac, one of the vaccines developed within the scope of combating the COVID-19 pandemic that has surrounded the world for a year, started to be applied in the first healthcare workers in our country. In this important step taken to end the pandemic, information on vaccines is still limited. Most vaccines, including the Coronavac vaccine, are applied with approval for emergency use before phase 3 studies are fully completed. While investigating the effect of the vaccine on the virus, possible side effects should also be considered. In this context, it is not known whether the vaccine has an effect on the menstrual cycle, especially of women of reproductive age.
Our primary aim in our study is to evaluate the effect of the vaccine on the menstrual cycle and if the vaccine has any effect on the menstrual cycle, what kind of changes this effect causes.
Conditions
- Covid19
- Vaccine Reaction
- Coronavirus
- Menstrual Problem
- Endometrium
Interventions
- OTHER
-
healthcare workers with the coronavac vaccine
Health workers who are vaccinated will fill in the 20-question survey electronically.
Sponsors & Collaborators
-
Kanuni Sultan Suleyman Training and Research Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-18
- Primary Completion
- 2021-05-07
- Completion
- 2021-05-09
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon
NCT03869866 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial
NCT05035238 ·Status: WITHDRAWN ·Phase: PHASE2
-
Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey
NCT05150496 ·Status: SUSPENDED ·Phase: PHASE2
-
Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults
NCT04866069 ·Status: TERMINATED ·Phase: PHASE1
-
Booster Vaccination Against COVID-19
NCT04979949 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Vaccines Safety Tracking (CoVaST)
NCT04834869 ·Status: RECRUITING
-
COVID-19 Vaccine Effectiveness Among Health Workers in Georgia
NCT04868448 ·Status: UNKNOWN
-
Study on the Epidemiological Characteristics of Female HPV Vaccination in China
NCT05932563 ·Status: UNKNOWN
-
Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women
NCT06997653 ·Status: WITHDRAWN ·Phase: PHASE2
-
Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.
NCT05857176 ·Status: COMPLETED
-
Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19)
NCT05128721 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine
NCT04962893 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness of Moderna COVID-19 Vaccine
NCT05933304 ·Status: COMPLETED
-
Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers
NCT04795414 ·Status: UNKNOWN
-
Clinical Trial For SARS-CoV-2 Vaccine (COVID-19)
NCT04582344 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Clinical Trial With New SARS-CoV-2 CoVacHGMix Type 5 Adenoviral Vector Vaccine
NCT05526183 ·Status: UNKNOWN ·Phase: PHASE1
-
Immunisation for Adolescents Against Serious Communicable Diseases (B Part of it NT)
NCT04398849 ·Status: UNKNOWN
-
Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine
NCT04942405 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults
NCT04546841 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
NCT05680454 ·Status: COMPLETED ·Phase: PHASE1
-
Monovalent Recombinant COVID19 Vaccine
NCT04453852 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females
NCT01462357 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness Study of Gardasil on Condyloma
NCT01553994 ·Status: COMPLETED
-
Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years
NCT00290277 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age.
NCT02459262 ·Status: COMPLETED ·Phase: PHASE1